Dragonfly Selected for Ministry of Health and Welfare R&D Project on Digital Therapeutic Devices... 1.7 Billion KRW Support Over 3 Years

Dragonfly announced on the 22nd that it has been selected for the "Digital Healthcare Demonstration and Adoption Based on Medical Institutions" project, part of the "2023 2nd Health and Medical Technology R&D Project" led by the Ministry of Health and Welfare, to focus on the commercialization of game-based digital therapeutics.

Starting this year, Dragonfly will receive approximately 1.7 billion KRW in government support over three years to accelerate the clinical demonstration and commercialization of the game-based digital therapeutic device "Guardians DTx" (tentative name).

The 2nd Health and Medical Technology R&D Project is conducted as part of the government's 3rd Basic Plan for Health and Medical Technology Promotion. The government supports the development of next-generation promising biohealth technologies, including digital therapeutics, with the goal of "realizing a Healthcare 4.0 era where all citizens are healthy."

Dragonfly, which has identified digital therapeutics as a new business, developed Guardians DTx to assist in the treatment of ADHD (Attention Deficit Hyperactivity Disorder) in children aged 7 to under 13. Currently, exploratory clinical trials targeting pediatric patients are underway in collaboration with Pusan National University Hospital and Pusan National University Industry-Academic Cooperation Foundation.

Building on the selection for this national project, Dragonfly has established conditions for collecting various real-world usage data and commercializing the product in partnership with Seoul National University Hospital, Daegu Catholic University Hospital, and Wonkwang University Hospital. Medical professionals collaborating with Dragonfly possess clinical and product design expertise, conducting clinical research on neurofeedback, a game-based ADHD brain training therapy.

Meanwhile, Dragonfly became the first domestic game company to participate in the international medical device and hospital equipment exhibition "KIMES 2023" last March. At that time, Guardians DTx was unveiled, attracting keen interest from domestic and international pharmaceutical companies.

A Dragonfly representative stated, "The selection for the national project has recognized the business potential of our digital therapeutic device product," adding, "We will secure various evidence data to obtain approval from the Ministry of Food and Drug Safety and prove efficacy, presenting a digital therapeutic device that can be used efficiently and safely by both medical professionals and users after commercialization."

This content was produced with the assistance of AI translation services.